China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
China Resources Pharmaceutical Group Ltd. announced that its subsidiary, CR Pharmaceutical Commercial, has received approval for the registration of asset-backed notes worth up to RMB15 billion in China. The proceeds from these notes, if issued, will primarily be used to replenish working capital. Investors are advised to exercise caution as the issuance may or may not proceed.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
